TRxADE HEALTH
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TRxADE HEALTH generated cash of -$2,073,601, which is less than the previous year. Cash used in financing activities reached the amount of $1,406,332 last year. Net change in cash is therefore -$942,986.
Cash Flow
| 2014 | -1.06M | 0 | 1.68M |
|---|---|---|---|
| 2015 | -1.20M | -1.11M | 1.35M |
| 2016 | -1.31M | -78K | 1.17M |
| 2017 | 171.67K | 0 | -2.43K |
| 2018 | 273.38K | -265.27K | 677.53K |
| 2019 | 141.77K | -332.25K | 2.19M |
| 2020 | -2.21M | -37.50K | 5.30M |
| 2021 | -2.56M | -22.59K | -208.17K |
| 2022 | -1.52M | -427.84K | -35.17K |
| 2023 | -2.07M | -275.71K | 1.40M |
MEDS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.09M | 3.12M | 5.91M | 2.87M | 869.55K | 183.91K | 14.67K | 78.70K | 705.60K | 84.31K |
Operating activities | ||||||||||
Net income | -13.72M | -3.90M | -5.31M | -2.53M | -284.42K | 9.03K | 288.98K | -1.17M | -1.11M | -2.01M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.04M | 195.85K | 138.90K | 102.52K | 94.73K | 0 | 0 | 0 | 3.80K | 4.8K |
Stock-based compensation expense | 257.77K | 254.10K | 181.16K | 1.35M | 281.82K | 0 | 280.33K | 0 | 355.11K | 0 |
| Deferred income tax benefit | 257.77K | 254.10K | 181.16K | 1.35M | 281.82K | 0 | 280.33K | 0 | 355.11K | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -293.78K | 496.69K | -789.58K | -23.53K | -369.92K | -1.53K | -20.35K | 55.77K | -172.60K | -255.06K |
Inventories | 4.23M | -63.30K | 825.12K | -2.41M | 23.20K | -3.81K | 0 | 0 | -255.16K | -3.05K |
Accounts payable | 1.60M | 252.12K | 220.19K | -33.19K | -148.65K | 95.14K | -98.21K | 16.49K | 65.1K | 128.74K |
Cash generated by operating activities | -2.07M | -1.52M | -2.56M | -2.21M | 141.77K | 273.38K | 171.67K | -1.31M | -1.20M | -1.06M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | -250K | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | -450.84K | -22.59K | -37.50K | -82.25K | -15.00K | 0 | 0 | 0 | 0 |
Acquisitions Net | -344.45K | 23K | 0 | 0 | -250K | -250.27K | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -275.71K | -427.84K | -22.59K | -37.50K | -332.25K | -265.27K | 0 | -78K | -1.11M | 0 |
Financing activities | ||||||||||
Common Stock Issued | 518.02K | 130.91K | 16.82K | 5.99M | 2.45M | 800K | 250K | 300K | 1.66K | 1.20M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 250K | 0 | -225K | 0 | -262.55K | -122.46K | -252.68K | -104.73K | 405K | -115.63K |
Cash used in financing activities | 1.40M | -35.17K | -208.17K | 5.30M | 2.19M | 677.53K | -2.43K | 1.17M | 1.35M | 1.68M |
Net Change In Cash | -942.98K | -1.98M | -2.79M | 3.04M | 2.00M | 685.64K | 169.23K | -64.02K | 154.53K | 621.28K |
Cash at end of period | 151.90K | 1.13M | 3.12M | 5.91M | 2.87M | 869.55K | 183.91K | 14.67K | 860.13K | 705.60K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |